FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Arlene Chapman

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Physiology

Concepts & Ideas

Living Beings

Genes & Molecular Sequences

Single Nucleotide Polymorphism

Co-author Network

Publications

TOP 3
Julio Duarte; Yan Gong; John G Gums; K R Bailey; Amber L Beitelshees; Eric Boerwinkle; Arlene B Chapman; Rhonda M Cooper-DeHoff; Taimour Y Langaee; B Tran; Stephen T Turner; Julie A Johnson
Association of chromosome 12 locus with antihypertensive response to hydrochlorothiazide may involve differential YEATS4 expression.
Caitrin W McDonough; Carl J Pepine; Stephen T Turner; Taimour Y Langaee; Kent R Bailey; Amber L Beitelshees; Eric Boerwinkle; Sarah E Burbage; Arlene B Chapman; Rhonda M Cooper-DeHoff; Julio Duarte; Yan Gong; John G Gums; Julie A Johnson
Association of variants in NEDD4L with blood pressure response and adverse cardiovascular outcomes in hypertensive patients treated with thiazide diuretics.
William R Wikoff; Hongjie Zhu; Amber L Beitelshees; Stephen Boyle; Arlene B Chapman; Erik Churchill; Rhonda M Cooper-DeHoff; Oliver Fiehn; Reginald F Frye; Yan Gong; Julie A Johnson; Rima Kaddurah-Daouk
Pharmacometabolomics reveals racial differences in response to atenolol treatment.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Arlene Chapman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Julio Duarte; Yan Gong; John G Gums; K R Bailey; Amber L Beitelshees; Eric Boerwinkle; Arlene B Chapman; Rhonda M Cooper-DeHoff; Taimour Y Langaee; B Tran; Stephen T Turner; Julie A Johnson
Association of chromosome 12 locus with antihypertensive response to hydrochlorothiazide may involve differential YEATS4 expression.
The pharmacogenomics journal 2013;13(3):257-63.
2013: Caitrin W McDonough; Carl J Pepine; Stephen T Turner; Taimour Y Langaee; Kent R Bailey; Amber L Beitelshees; Eric Boerwinkle; Sarah E Burbage; Arlene B Chapman; Rhonda M Cooper-DeHoff; Julio Duarte; Yan Gong; John G Gums; Julie A Johnson
Association of variants in NEDD4L with blood pressure response and adverse cardiovascular outcomes in hypertensive patients treated with thiazide diuretics.
Journal of hypertension 2013;31(4):698-704.
2013: William R Wikoff; Hongjie Zhu; Amber L Beitelshees; Stephen Boyle; Arlene B Chapman; Erik Churchill; Rhonda M Cooper-DeHoff; Oliver Fiehn; Reginald F Frye; Yan Gong; Julie A Johnson; Rima Kaddurah-Daouk
Pharmacometabolomics reveals racial differences in response to atenolol treatment.
PloS one 2013;8(3):e57639.
2013: High Seng Chai; Arlene B Chapman; Eric Boerwinkle
Response to genomic association analysis identifies multiple loci influencing antihypertensive response to an angiotensin II receptor blocker.
Hypertension 2013;61(1):e6.
2013: MyPhuong T Le; Maximilian T Lobmeyer; Stephen T Turner; Zhiying Wang; Eric Boerwinkle; Marcus Campbell; Arlene B Chapman; Jing Cheng; Yan Gong; John G Gums; Richard J Johnson; Julie A Johnson
Impact of genetic polymorphisms of SLC2A2, SLC2A5, and KHK on metabolic phenotypes in hypertensive individuals.
PloS one 2013;8(1):e52062.
2013: Andreas D Kistler; Fabienne Krauer; Mischak Harald; Michal Mrug; William Mullen; Diane Poster; Andreas L Serra; Justyna Siwy; Vicente E Torres; Rudolf P Wüthrich; Kyongtae T Bae; James E Bost; Jared J Grantham; Arlene B Chapman
Urinary proteomic biomarkers for diagnosis and risk stratification of autosomal dominant polycystic kidney disease: a multicentric study.
PloS one 2013;8(1):e53016.
2012: Vicente E Torres; Arlene B Chapman; Frank S Czerwiec; Olivier Devuyst; Ron T Gansevoort; Jared J Grantham; Eiji Higashihara; Holly B Krasa; John Ouyang; Ronald D Perrone
Tolvaptan in patients with autosomal dominant polycystic kidney disease.
The New England journal of medicine 2012;367(25):2407-18.
2012: Yan Gong; John G Gums; Wei Hou; Kent R Bailey; Amber L Beitelshees; Eric Boerwinkle; Arlene B Chapman; Rhonda M Cooper-DeHoff; Taimour Y Langaee; Caitrin W McDonough; Stephen T Turner; Zhiying Wang; Julie A Johnson
Hypertension susceptibility loci and blood pressure response to antihypertensives: results from the pharmacogenomic evaluation of antihypertensive responses study.
Circulation. Cardiovascular genetics 2012;5(6):686-91.
2012: Alexander G Vandell; Taimour Y Langaee; Stephen B Liggett; Maximilian T Lobmeyer; Carl J Pepine; Stephen T Turner; Kent R Bailey; Amber L Beitelshees; Eric Boerwinkle; Arlene B Chapman; Rhonda M Cooper-DeHoff; Brian E Gawronski; Yan Gong; John G Gums; Julie A Johnson
G protein receptor kinase 4 polymorphisms: β-blocker pharmacogenetics and treatment-related outcomes in hypertension.
Hypertension 2012;60(4):957-64.
2012: Stephen T Turner; Kent R Bailey; High Seng Chai; Arlene B Chapman; Gary L Schwartz; Eric Boerwinkle
Genomic association analysis identifies multiple loci influencing antihypertensive response to an angiotensin II receptor blocker.
Hypertension 2012;59(6):1204-11.
2012: Arlene B Chapman
The fetal environment: a critical phase that determines future renal outcomes in autosomal dominant polycystic kidney disease.
Kidney international 2012;81(9):814-5.
2012: Chirag R Parikh; Xin Tian; Raoul Zeltner; James E Bost; Arlene B Chapman; Diane M Comer; Neera K Dahl; Charles L Edelstein; Jared J Grantham; Stefan Somlo
Evaluation of urine biomarkers of kidney injury in polycystic kidney disease.
Kidney international 2012;81(8):784-90.
2012: Arlene B Chapman; Mike Flessner; Kyongtae T Bae; William M Bennett; James E Bost; Lisa M Guay-Woodford; Peter C Harris; Bernard F King; Douglas Landsittel; Jie Li; Mark E Lockhart; Diego Martin; Marva Moxey-Mims; Vicente E Torres; Louis H Wetzel; Jared J Grantham
Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease.
Clinical journal of the American Society of Nephrology : CJASN 2012;7(3):479-86.
2012: Vicente E Torres; Louis H Wetzel; Franz T Winklhofer; Kaleab Z Abebe; Kyongtae T Bae; James E Bost; William E Braun; Arlene B Chapman; James F Glockner; Neil J Halin; Marie C Hogan; Cass Kelleher; Diego R Martin; Amirali Masoumi; Catherine M Meyers; J. Philip Miller; Dana C Miskulin; Frederic R Oskoui; Nayana Patel; Ivan Pedrosa; Ronald D Perrone; Erick Remer; Robert W Schrier; Theodore I Steinman; Paul A Thompson
Analysis of baseline parameters in the HALT polycystic kidney disease trials.
Kidney international 2012;81(6):577-85.
2012: Steven M Smith; Stephen T Turner; Julie A Johnson; Kent Bailey; Amber L Beitelshees; Eric Boerwinkle; Arlene B Chapman; Rhonda M Cooper-DeHoff; Yan Gong; John G Gums
Blood pressure responses and metabolic effects of hydrochlorothiazide and atenolol.
American journal of hypertension 2012;25(3):359-65.
2012: Mohamed Shafiu; Stephen T Turner; Richard J Johnson; Taimour Y Langaee; Arlene B Chapman; Yan Gong; John G Gums; Julie A Johnson
Urate transporter gene SLC22A12 polymorphisms associated with obesity and metabolic syndrome in Caucasians with hypertension.
Kidney & blood pressure research 2012;35(6):477-82.
2012: Julio Duarte; Roger B Fillingim; Yan Gong; John G Gums; Kent R Bailey; Amber L Beitelshees; Eric Boerwinkle; Ben Burkley; Arlene B Chapman; Rhonda M Cooper-DeHoff; Bruce C Kone; Taimour Y Langaee; Stephen T Turner; Issam Zineh; Julie A Johnson
Effects of genetic variation in H3K79 methylation regulatory genes on clinical blood pressure and blood pressure response to hydrochlorothiazide.
Journal of translational medicine 2012;10():56.
2012: Stephen T Turner; Amber L Beitelshees; Eric Boerwinkle; Arlene B Chapman; Rhonda M Cooper-DeHoff; John G Gums; Julie A Johnson; Gary L Schwartz; Kent R Bailey
Power to identify a genetic predictor of antihypertensive drug response using different methods to measure blood pressure response.
Journal of translational medicine 2012;10():47.
2011: Eiji Higashihara; Shigeo Horie; Holly B Krasa; Kikuo Nutahara; John Ouyang; Vicente E Torres; Terry Watnick; Kyongtae Bae; Arlene B Chapman; Frank S Czerwiec; Jared J Grantham
Tolvaptan in autosomal dominant polycystic kidney disease: three years' experience.
Clinical journal of the American Society of Nephrology : CJASN 2011;6(10):2499-507.
2011: Ronald D Perrone; Frederic Rahbari-Oskoui; Erick Remer; Robert W Schrier; Theodore I Steinman; Paul Thompson; Vicente E Torres; Louis H Wetzel; Franz T Winklhofer; Kaleab Z Abebe; Kyongtae T Bae; James E Bost; William Braun; Arlene B Chapman; James F Glockner; Neil J Halin; Marie C Hogan; Diana Kaya; Cass Kelleher; Diego Martin; Amirali Masoumi; J. Philip Miller; Dana C Miskulin; Nayana Patel; Ivan Pedrosa; Catherine M Meyers
Cardiac magnetic resonance assessment of left ventricular mass in autosomal dominant polycystic kidney disease.
Clinical journal of the American Society of Nephrology : CJASN 2011;6(10):2508-15.
2011: Arlene B Chapman; Wenjing Wei
Imaging approaches to patients with polycystic kidney disease.
Seminars in nephrology 2011;31(3):237-44.
2011: Vicente E Torres; Esther Meijer; Kyongtae T Bae; Arlene B Chapman; Olivier Devuyst; Ron T Gansevoort; Jared J Grantham; Eiji Higashihara; Ronald D Perrone; Holly B Krasa; John J Ouyang; Frank S Czerwiec
Rationale and design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and its Outcomes) 3-4 Study.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2011;57(5):692-9.
2011: Tejas Desai; Darina Stankeyeva; Arlene B Chapman; James Bailey
Nephrology fellows show consistent use of, and improved knowledge from, a nephrologist-programmed teaching instrument.
Journal of nephrology 2011;24(3):345-50.
2011: Frederic F Rahbari-Oskoui; Dana C Miskulin; Marie C Hogan; Odicie Fielder; Vicente E Torres; James E Bost; Arlene B Chapman
Short-term reproducibility of ambulatory blood pressure monitoring in autosomal dominant polycystic kidney disease.
Blood pressure monitoring 2011;16(2):47-54.
2011: Vicente E Torres; Jared J Grantham; Arlene B Chapman; Michal Mrug; Kyongtae T Bae; Bernard F King; Louis H Wetzel; Diego Martin; Mark E Lockhart; William M Bennett; Marva Moxey-Mims; Kaleab Z Abebe; Yan Lin; James E Bost
Potentially modifiable factors affecting the progression of autosomal dominant polycystic kidney disease.
Clinical journal of the American Society of Nephrology : CJASN 2011;6(3):640-7.
2011: Maximilian T Lobmeyer; Liewei Wang; Issam Zineh; Stephen T Turner; John G Gums; Arlene B Chapman; Rhonda M Cooper-DeHoff; Amber L Beitelshees; Kent R Bailey; Eric Boerwinkle; Carl J Pepine; Julie A Johnson
Polymorphisms in genes coding for GRK2 and GRK5 and response differences in antihypertensive-treated patients.
Pharmacogenetics and genomics 2011;21(1):42-9.
2010: Stephen T Turner; Gary L Schwartz; Arlene B Chapman; Amber L Beitelshees; John G Gums; Rhonda M Cooper-DeHoff; Eric Boerwinkle; Julie A Johnson; Kent R Bailey
Plasma renin activity predicts blood pressure responses to beta-blocker and thiazide diuretic as monotherapy and add-on therapy for hypertension.
American journal of hypertension 2010;23(9):1014-22.
2010: Juling Zhou; Xiaosen Ouyang; Xiangqin Cui; Trenton R Schoeb; Lesley E Smythies; Martin R Johnson; Lisa M Guay-Woodford; Arlene B Chapman; Michal Mrug
Renal CD14 expression correlates with the progression of cystic kidney disease.
Kidney international 2010;78(6):550-60.
2010: Julio Duarte; Maximilian T Lobmeyer; Zhiying Wang; Arlene B Chapman; John G Gums; Taimour Y Langaee; Eric Boerwinkle; Stephen T Turner; Julie A Johnson
Lack of association between polymorphisms in STK39, a putative thiazide response gene, and blood pressure response to hydrochlorothiazide.
Pharmacogenetics and genomics 2010;20(8):516-9.
2010: Vicente E Torres; Alessandra Boletta; Arlene B Chapman; Vincent Gattone; York Pei; Qi Qian; Darren P Wallace; Thomas Weimbs; Rudolf P Wüthrich
Prospects for mTOR inhibitor use in patients with polycystic kidney disease and hamartomatous diseases.
Clinical journal of the American Society of Nephrology : CJASN 2010;5(7):1312-29.
2010: Samuel Dambreville; Arlene B Chapman; Vicente E Torres; Bernard F King; Ashley K Wallin; David H Frakes; Ajit P Yoganathan; Sameera R Wijayawardana; Kirk Easley; Kyongtae T Bae; Marijn E Brummer
Renal arterial blood flow measurement by breath-held MRI: Accuracy in phantom scans and reproducibility in healthy subjects.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 2010;63(4):940-50.
2010: Sandra L Taylor; Sheila Ganti; Nikolay O Bukanov; Arlene B Chapman; Oliver Fiehn; Michael Osier; Kyoungmi Kim; Robert H Weiss
A metabolomics approach using juvenile cystic mice to identify urinary biomarkers and altered pathways in polycystic kidney disease.
American journal of physiology. Renal physiology 2010;298(4):F909-22.
2010: Arlene B Chapman; Konrad Stepniakowski; Frederic Rahbari-Oskoui
Hypertension in autosomal dominant polycystic kidney disease.
Advances in chronic kidney disease 2010;17(2):153-63.
2010: Diego R Martin; Saravanan K Krishnamoorthy; Bobby Kalb; Khalil Salman; Puneet Sharma; John D Carew; Phillip A Martin; Arlene B Chapman; Gaye L Ray; Christian P Larsen; Thomas C Pearson
Decreased incidence of NSF in patients on dialysis after changing gadolinium contrast-enhanced MRI protocols.
Journal of magnetic resonance imaging : JMRI 2010;31(2):440-6.
2010: Arlene B Chapman; Vicente E Torres; Ronald D Perrone; Theodore I Steinman; Kyongtae T Bae; J. Philip Miller; Dana C Miskulin; Frederic Rahbari Oskoui; Amirali Masoumi; Marie C Hogan; Franz T Winklhofer; William Braun; Paul Thompson; Catherine M Meyers; Cass Kelleher; Robert W Schrier
The HALT polycystic kidney disease trials: design and implementation.
Clinical journal of the American Society of Nephrology : CJASN 2010;5(1):102-9.
2010: Amber L Beitelshees; Yan Gong; Kent R Bailey; Stephen T Turner; Arlene B Chapman; Gary L Schwartz; John G Gums; Eric Boerwinkle; Julie A Johnson
Comparison of office, ambulatory, and home blood pressure antihypertensive response to atenolol and hydrochlorthiazide.
Journal of clinical hypertension (Greenwich, Conn.) 2010;12(1):14-21.
2010: Rhonda M Cooper-DeHoff; Sheron Wen; Amber L Beitelshees; Issam Zineh; John G Gums; Stephen T Turner; Yan Gong; Karen Hall; Vishal Parekh; Arlene B Chapman; Eric Boerwinkle; Julie A Johnson
Impact of abdominal obesity on incidence of adverse metabolic effects associated with antihypertensive medications.
Hypertension 2010;55(1):61-8.
2009: Diego R Martin; Richard C Semelka; Arlene B Chapman; Harm Peters; Paul J Finn; Bobby Kalb; Henrik Thomsen
Nephrogenic systemic fibrosis versus contrast-induced nephropathy: risks and benefits of contrast-enhanced MR and CT in renally impaired patients.
Journal of magnetic resonance imaging : JMRI 2009;30(6):1350-6.
2009: Julie A Johnson; Yan Gong; kent bailey; Rhonda M Cooper-DeHoff; Arlene B Chapman; S T Turner; G L Schwartz; K Campbell; S Schmidt; Amber L Beitelshees; Eric Boerwinkle; John G Gums
Hydrochlorothiazide and atenolol combination antihypertensive therapy: effects of drug initiation order.
Clinical pharmacology and therapeutics 2009;86(5):533-9.
2009: Steven M Smith; Shawn D Anderson; Sheron Wen; Yan Gong; Stephen T Turner; Rhonda M Cooper-DeHoff; Gary L Schwartz; Kent Bailey; Arlene B Chapman; Karen L Hall; Hua Feng; Eric Boerwinkle; Julie A Johnson; John G Gums
Lack of correlation between thiazide-induced hyperglycemia and hypokalemia: subgroup analysis of results from the pharmacogenomic evaluation of antihypertensive responses (PEAR) study.
Pharmacotherapy 2009;29(10):1157-65.
2009: Maja Barbalic; Gary L Schwartz; Arlene B Chapman; Stephen T Turner; Eric Boerwinkle
Kininogen gene (KNG) variation has a consistent effect on aldosterone response to antihypertensive drug therapy: the GERA study.
Physiological genomics 2009;39(1):56-60.
2009: Arlene B Chapman
Polycystic kidney disease: The cadence of kidney growth in ADPKD.
Nature reviews. Nephrology 2009;5(6):311-2.
2009: Arlene B Chapman; Lisa M Guay-Woodford
Renal volume in children with ADPKD: size matters.
Clinical journal of the American Society of Nephrology : CJASN 2009;4(4):698-9.
2009: Kyongtae T Bae; Cheng Tao; Fang Zhu; James E Bost; Arlene B Chapman; Jared J Grantham; Vicente E Torres; Lisa M Guay-Woodford; Catherine M Meyers; William M Bennett
MRI-based kidney volume measurements in ADPKD: reliability and effect of gadolinium enhancement.
Clinical journal of the American Society of Nephrology : CJASN 2009;4(4):719-25.
2009: Dana Rizk; Claudine Jurkovitz; Emir Veledar; Susan P Bagby; Deborah A Baumgarten; Frederic Rahbari-Oskoui; Theodore Steinman; Arlene B Chapman
Quality of life in autosomal dominant polycystic kidney disease patients not yet on dialysis.
Clinical journal of the American Society of Nephrology : CJASN 2009;4(3):560-6.
2009: Julie A Johnson; Eric Boerwinkle; Issam Zineh; Arlene B Chapman; Kent Bailey; Rhonda M Cooper-DeHoff; John G Gums; R Whit Curry; Yan Gong; Amber L Beitelshees; Gary Schwartz; Stephen T Turner
Pharmacogenomics of antihypertensive drugs: rationale and design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study.
American heart journal 2009;157(3):442-9.
2009: Arlene B Chapman
Improving clinical trial design for inquiries into the mechanisms of cyst growth in ADPKD.
Kidney international 2009;75(2):139-41.
2008: Mark B Consugar; Wai C Wong; Patrick A Lundquist; Sandro Rossetti; Vickie Kubly; Denise L Walker; Laureano J Rangel; Richard Aspinwall; W Patrick Niaudet; Seza Ozen; Albert David; Milen Velinov; Erik J Bergstralh; Kyongtae T Bae; Arlene B Chapman; Lisa M Guay-Woodford; Jared J Grantham; Vicente E Torres; Julian R Sampson; Brian D Dawson; Peter C Harris
Characterization of large rearrangements in autosomal dominant polycystic kidney disease and the PKD1/TSC2 contiguous gene syndrome.
Kidney international 2008;74(11):1468-79.
2008: Arlene B Chapman; Lisa M Guay-Woodford
Nurturing passion in a time of academic climate change: the modern-day challenge of junior faculty development.
Clinical journal of the American Society of Nephrology : CJASN 2008;3(6):1878-83.
2008: Stephen T Turner; kent bailey; Brooke L Fridley; Arlene B Chapman; Gary L Schwartz; High Seng Chai; Hugues Sicotte; Jean-Pierre Kocher; Andréi S Rodin; Eric Boerwinkle
Genomic association analysis suggests chromosome 12 locus influencing antihypertensive response to thiazide diuretic.
Hypertension 2008;52(2):359-65.
2008: Arlene B Chapman
Approaches to testing new treatments in autosomal dominant polycystic kidney disease: insights from the CRISP and HALT-PKD studies.
Clinical journal of the American Society of Nephrology : CJASN 2008;3(4):1197-204.
2008: Dana Rizk; Arlene B Chapman
Treatment of autosomal dominant polycystic kidney disease (ADPKD): the new horizon for children with ADPKD.
Pediatric nephrology (Berlin, Germany) 2008;23(7):1029-36.
2008: Vincent J Canzanello; Evelyn Baranco-Pryor; Frederic Rahbari-Oskoui; Gary L Schwartz; Eric Boerwinkle; Stephen T Turner; Arlene B Chapman
Predictors of blood pressure response to the angiotensin receptor blocker candesartan in essential hypertension.
American journal of hypertension 2008;21(1):61-6.
2008: Jared J Grantham; Larry T Cook; V E Torres; J E Bost; Arlene B Chapman; P C Harris; Lisa M Guay-Woodford; K T Bae
Determinants of renal volume in autosomal-dominant polycystic kidney disease.
Kidney international 2008;73(1):108-16.
2007: Sandro Rossetti; Mark B Consugar; Arlene B Chapman; Vicente E Torres; Lisa M Guay-Woodford; Jared J Grantham; William M Bennett; Catherine M Meyers; Denise L Walker; Kyongtae Bae; Qin Jean Zhang; Paul Thompson; Philip Miller; Peter C Harris
Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease.
Journal of the American Society of Nephrology : JASN 2007;18(7):2143-60.
2007: Guillermo E Umpierrez; Paul Cantey; Dawn Smiley; Andres Palacio; Diana Temponi; Karen Luster; Arlene B Chapman
Primary aldosteronism in diabetic subjects with resistant hypertension.
Diabetes care 2007;30(7):1699-703.
2007: Arlene B Chapman
Autosomal dominant polycystic kidney disease: time for a change?
Journal of the American Society of Nephrology : JASN 2007;18(5):1399-407.
2007: Vicente E Torres; Bernard F King; Arlene B Chapman; Marijn E Brummer; Kyongtae T Bae; James F Glockner; Kraisthith Arya; Dana Risk; Joel P Felmlee; Jared J Grantham; Lisa M Guay-Woodford; William M Bennett; Saulo Klahr; Catherine M Meyers; Xiaoling Zhang; Paul Thompson; Philip Miller
Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease.
Clinical journal of the American Society of Nephrology : CJASN 2007;2(1):112-20.
2007: Adeera Levin; Stuart Linas; Friedrich C Luft; Arlene B Chapman; Stephen Textor
Controversies in renal artery stenosis: a review by the American Society of Nephrology Advisory Group on Hypertension.
American journal of nephrology 2007;27(2):212-20.
2006: Peter C Harris; Kyongtae T Bae; Sandro Rossetti; Vicente E Torres; Jared J Grantham; Arlene B Chapman; Lisa M Guay-Woodford; Bernard F King; Louis H Wetzel; Deborah A Baumgarten; Philip J Kenney; Mark B Consugar; Saulo Klahr; William M Bennett; Catherine M Meyers; Qin Jean Zhang; Paul Thompson; Fang Zhu; Philip Miller
Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney disease.
Journal of the American Society of Nephrology : JASN 2006;17(11):3013-9.
2006: Jared J Grantham; Vicente E Torres; Arlene B Chapman; Lisa M Guay-Woodford; Kyongtae T Bae; Bernard F King; Louis H Wetzel; Deborah A Baumgarten; Philip J Kenney; Peter C Harris; Saulo Klahr; William M Bennett; Gladys N Hirschman; Catherine M Meyers; Xiaoling Zhang; Fang Zhu; J. Philip Miller
Volume progression in polycystic kidney disease.
The New England journal of medicine 2006;354(20):2122-30.
2006: Andrew D Rule; Vicente E Torres; Arlene B Chapman; Jared J Grantham; Lisa M Guay-Woodford; Kyongtae T Bae; Saulo Klahr; William M Bennett; Catherine M Meyers; Paul Thompson; Philip Miller
Comparison of methods for determining renal function decline in early autosomal dominant polycystic kidney disease: the consortium of radiologic imaging studies of polycystic kidney disease cohort.
Journal of the American Society of Nephrology : JASN 2006;17(3):854-62.
2006: Jared J Grantham; Arlene B Chapman; Vicente E Torres
Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes.
Clinical journal of the American Society of Nephrology : CJASN 2006;1(1):148-57.
2006: Kyongtae T Bae; Fang Zhu; Arlene B Chapman; Vicente E Torres; Jared J Grantham; Lisa M Guay-Woodford; Deborah A Baumgarten; Bernard F King; Louis H Wetzel; Philip J Kenney; Marijn E Brummer; William M Bennett; Saulo Klahr; Catherine M Meyers; Xiaoling Zhang; Paul Thompson; Philip Miller
Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort.
Clinical journal of the American Society of Nephrology : CJASN 2006;1(1):64-9.
2005: W Charles O'neill; Michelle L Robbin; Kyongtae T Bae; Jared J Grantham; Arlene B Chapman; Lisa M Guay-Woodford; Vicente E Torres; Bernard F King; Louis H Wetzel; Paul Thompson; Philip Miller
Sonographic assessment of the severity and progression of autosomal dominant polycystic kidney disease: the Consortium of Renal Imaging Studies in Polycystic Kidney Disease (CRISP).
American journal of kidney diseases : the official journal of the National Kidney Foundation 2005;46(6):1058-64.
2005: Stephen T Turner; Gary L Schwartz; Arlene B Chapman; Eric Boerwinkle
WNK1 kinase polymorphism and blood pressure response to a thiazide diuretic.
Hypertension 2005;46(4):758-65.
2005: Anke Hilse Maitland-van der Zee; Stephen T Turner; Gary L Schwartz; Arlene B Chapman; Olaf Klungel; Eric Boerwinkle
Demographic, environmental, and genetic predictors of metabolic side effects of hydrochlorothiazide treatment in hypertensive subjects.
American journal of hypertension 2005;18(8):1077-83.
2005: Anke Hilse Maitland-van der Zee; Stephen T Turner; Gary L Schwartz; Arlene B Chapman; Olaf Klungel; Eric Boerwinkle
A multilocus approach to the antihypertensive pharmacogenetics of hydrochlorothiazide.
Pharmacogenetics and genomics 2005;15(5):287-93.
2005: Javier D Finkielman; Gary L Schwartz; Arlene B Chapman; Eric Boerwinkle; Stephen T Turner
Lack of agreement between office and ambulatory blood pressure responses to hydrochlorothiazide.
American journal of hypertension 2005;18(3):398-402.
2004: L Frazier; S T Turner; Gary L Schwartz; Arlene B Chapman; E Boerwinkle
Multilocus effects of the renin-angiotensin-aldosterone system genes on blood pressure response to a thiazide diuretic.
The pharmacogenomics journal 2004;4(1):17-23.
2003: Dana Rizk; Arlene B Chapman
Cystic and inherited kidney diseases.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2003;42(6):1305-17.
2003: Bernard F King; Vicente E Torres; Marijn E Brummer; Arlene B Chapman; Kyongtae T Bae; James F Glockner; Kraisthith Arya; Joel P Felmlee; Jared J Grantham; Lisa M Guay-Woodford; William M Bennett; Saulo Klahr; Gladys H Hirschman; Paul L Kimmel; Paul Thompson; Philip Miller
Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney disease.
Kidney international 2003;64(6):2214-21.
2003: Robert W Schrier; Ann M Johnson; Kim McFann; Arlene B Chapman
The role of parental hypertension in the frequency and age of diagnosis of hypertension in offspring with autosomal-dominant polycystic kidney disease.
Kidney international 2003;64(5):1792-9.
2003: Stephen T Turner; Arlene B Chapman; Gary L Schwartz; Eric Boerwinkle
Effects of endothelial nitric oxide synthase, alpha-adducin, and other candidate gene polymorphisms on blood pressure response to hydrochlorothiazide.
American journal of hypertension 2003;16(10):834-9.
2003: Arlene B Chapman; Lisa M Guay-Woodford; Jared J Grantham; Vicente E Torres; Kyongtae T Bae; Deborah A Baumgarten; Philip J Kenney; Bernard F King; James F Glockner; Louis H Wetzel; Marijn E Brummer; W Charles O'neill; Michelle L Robbin; William M Bennett; Saulo Klahr; Gladys H Hirschman; Paul L Kimmel; Paul Thompson; Philip Miller
Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort.
Kidney international 2003;64(3):1035-45.
2003: Mark M Belz; Godela M Fick-Brosnahan; Richard L Hughes; David Rubinstein; Arlene B Chapman; Ann M Johnson; Kim McFann; William D Kaehny; Patricia Gabow
Recurrence of intracranial aneurysms in autosomal-dominant polycystic kidney disease.
Kidney international 2003;63(5):1824-30.
2003: Arlene B Chapman
Cystic disease in women: clinical characteristics and medical management.
Advances in renal replacement therapy 2003;10(1):24-30.
2002: Javier D Finkielman; Gary L Schwartz; Arlene B Chapman; Eric Boerwinkle; Stephen T Turner
Reproducibility of blood pressure response to hydrochlorothiazide.
Journal of clinical hypertension (Greenwich, Conn.) 2002;4(6):408-12.
2002: Gary L Schwartz; Arlene B Chapman; Eric Boerwinkle; Robert M Kisabeth; Stephen T Turner
Screening for primary aldosteronism: implications of an increased plasma aldosterone/renin ratio.
Clinical chemistry 2002;48(11):1919-23.
2002: Gary L Schwartz; Stephen T Turner; Arlene B Chapman; Eric Boerwinkle
Interacting effects of gender and genotype on blood pressure response to hydrochlorothiazide.
Kidney international 2002;62(5):1718-23.
2002: Robert W Schrier; Kim McFann; Ann Johnson; Arlene B Chapman; Charles L Edelstein; Godela Brosnahan; Tevfik Ecder; Lyn Tison
Cardiac and renal effects of standard versus rigorous blood pressure control in autosomal-dominant polycystic kidney disease: results of a seven-year prospective randomized study.
Journal of the American Society of Nephrology : JASN 2002;13(7):1733-9.
2002: Arlene B Chapman; Gary L Schwartz; Eric Boerwinkle; Stephen T Turner
Predictors of antihypertensive response to a standard dose of hydrochlorothiazide for essential hypertension.
Kidney international 2002;61(3):1047-55.
2001: Stephen T Turner; Gary L Schwartz; Arlene B Chapman; Eric Boerwinkle
Use of gene markers to guide antihypertensive therapy.
Current hypertension reports 2001;3(5):410-5.
2001: Victor Montori; Gary L Schwartz; Arlene B Chapman; E Boerwinkle; S T Turner
Validity of the aldosterone-renin ratio used to screen for primary aldosteronism.
Mayo Clinic proceedings. Mayo Clinic 2001;76(9):877-82.
2001: Tevfik Ecder; Charles L Edelstein; Godela M Fick-Brosnahan; Ann M Johnson; Arlene B Chapman; Patricia Gabow; Robert W Schrier
Diuretics versus angiotensin-converting enzyme inhibitors in autosomal dominant polycystic kidney disease.
American journal of nephrology 2001;21(2):98-103.
2001: Stephen T Turner; Gary L Schwartz; Arlene B Chapman; Eric Boerwinkle
C825T polymorphism of the G protein beta(3)-subunit and antihypertensive response to a thiazide diuretic.
Hypertension 2001;37(2 Pt 2):739-43.
2001: Stephen T Turner; Gary L Schwartz; Arlene B Chapman; W D Hall; Eric Boerwinkle
Antihypertensive pharmacogenetics: getting the right drug into the right patient.
Journal of hypertension 2001;19(1):1-11.
2000: Tevfik Ecder; Arlene B Chapman; Godela Brosnahan; Charles L Edelstein; Ann M Johnson; Robert W Schrier
Effect of antihypertensive therapy on renal function and urinary albumin excretion in hypertensive patients with autosomal dominant polycystic kidney disease.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2000;35(3):427-32.
2000: Barry I Freedman; J Michael Soucie; Arlene B Chapman; Jenna Krisher; William M McClellan
Racial variation in autosomal dominant polycystic kidney disease.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2000;35(1):35-9.
1999: Tevfik Ecder; Charles L Edelstein; Arlene B Chapman; Ann M Johnson; L Tison; E A Gill; Godela Brosnahan; Robert W Schrier
Reversal of left ventricular hypertrophy with angiotensin converting enzyme inhibition in hypertensive patients with autosomal dominant polycystic kidney disease.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1999;14(5):1113-6.
1998: Arlene B Chapman; William T Abraham; Stacy Zamudio; C Coffin; Aicha Merouani; D Young; A Johnson; F Osorio; C Goldberg; L G Moore; TE Dahms; Robert W Schrier
Temporal relationships between hormonal and hemodynamic changes in early human pregnancy.
Kidney international 1998;54(6):2056-63.
1998: Arlene B Chapman
The structure-function relationship in preeclampsia.
Kidney international 1998;54(4):1394-5.
1997: Arlene B Chapman; Stacy Zamudio; Whitney W Woodmansee; Aicha Merouani; F Osorio; A Johnson; Lorna G Moore; TE Dahms; C Coffin; William T Abraham; Robert W Schrier
Systemic and renal hemodynamic changes in the luteal phase of the menstrual cycle mimic early pregnancy.
The American journal of physiology 1997;273(5 Pt 2):F777-82.
1997: Arlene B Chapman; Patricia Gabow
Hypertension in autosomal dominant polycystic kidney disease.
Kidney international. Supplement 1997;61():S71-3.
1997: Arlene B Chapman; A M Johnson; S Rainguet; K Hossack; Patricia Gabow; R W Schrier
Left ventricular hypertrophy in autosomal dominant polycystic kidney disease.
Journal of the American Society of Nephrology : JASN 1997;8(8):1292-7.
1994: Arlene B Chapman; Ann M Johnson; Patricia Gabow; Robert W Schrier
Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease.
Journal of the American Society of Nephrology : JASN 1994;5(6):1349-54.
1994: Arlene B Chapman; Ann M Johnson; Patricia Gabow
Pregnancy outcome and its relationship to progression of renal failure in autosomal dominant polycystic kidney disease.
Journal of the American Society of Nephrology : JASN 1994;5(5):1178-85.
1993: Arlene B Chapman; Ann M Johnson; Patricia Gabow
Intracranial aneurysms in patients with autosomal dominant polycystic kidney disease: how to diagnose and who to screen.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1993;22(4):526-31.
1993: S T Shaikewitz; Arlene B Chapman
Autosomal recessive polycystic kidney disease: issues regarding the variability of clinical presentation.
Journal of the American Society of Nephrology : JASN 1993;3(12):1858-62.
1992: Arlene B Chapman; David Rubinstein; R Hughes; JC Stears; M P Earnest; Ann M Johnson; Patricia Gabow; W D Kaehny
Intracranial aneurysms in autosomal dominant polycystic kidney disease.
The New England journal of medicine 1992;327(13):916-20.
1991: Arlene B Chapman; Patricia Gabow; Robert W Schrier
Reversible renal failure associated with angiotensin-converting enzyme inhibitors in polycystic kidney disease.
Annals of internal medicine 1991;115(10):769-73.
1991: Arlene B Chapman; Robert W Schrier
Pathogenesis of hypertension in autosomal dominant polycystic kidney disease.
Seminars in nephrology 1991;11(6):653-60.
1990: Patricia Gabow; Arlene B Chapman; Ann M Johnson; D J Tangel; I T Duley; W D Kaehny; M Manco-Johnson; Robert W Schrier
Renal structure and hypertension in autosomal dominant polycystic kidney disease.
Kidney international 1990;38(6):1177-80.
1990: Arlene B Chapman; A Johnson; Patricia Gabow; Robert W Schrier
The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease.
The New England journal of medicine 1990;323(16):1091-6.
1990: Arlene B Chapman; D Thickman; Patricia Gabow
Percutaneous cyst puncture in the treatment of cyst infection in autosomal dominant polycystic kidney disease.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1990;16(3):252-5.